TrialThe oncologist2021

TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study.

Emeline Tabouret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.